CNBX Pharmaceuticals Inc. (CNBX) stock
CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $197.79KP/E –Yield –
CNBX Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
CNBX Pharmaceuticals's cash was $9.49K at May 31, 2026. For fiscal 2025 it was $15.11K, down 42.8% from the year before. Over ten years it grew -5.0% a year on average. The highest annual figure on record is $3.52M in fiscal 2019.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $15.11K | -42.8% |
| FY2024 | Aug 31, 2024 | $26.42K | -79.6% |
| FY2023 | Aug 31, 2023 | $129.70K | +10.4% |
| FY2022 | Aug 31, 2022 | $117.52K | -91.5% |
| FY2021 | Aug 31, 2021 | $1.39M | +78.3% |
| FY2020 | Aug 31, 2020 | $777.61K | -77.9% |
| FY2019 | Aug 31, 2019 | $3.52M | +152.8% |
| FY2018 | Aug 31, 2018 | $1.39M | 0.0% |
| FY2017 | Aug 31, 2017 | $1.39M | +7186.1% |
| FY2016 | Aug 31, 2016 | $19.13K | -24.2% |
| FY2015 | Aug 31, 2015 | $25.23K | -74.5% |
| FY2014 | Aug 31, 2014 | $98.77K | – |
| FY2013 | Aug 31, 2013 | $0 | – |
| FY2012 | Aug 31, 2012 | $0 | – |
| FY2011 | Aug 31, 2011 | $0 | -100.0% |
| FY2009 | Aug 31, 2009 | $177.74K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | May 31, 2026 | $9.49K | -30.5% |
| Q2 FY2026CQ1 2026 | Feb 28, 2026 | $12.15K | -73.4% |
| Q1 FY2026CQ4 2025 | Nov 30, 2025 | $7.70K | -55.6% |
| Q4 FY2025CQ3 2025 | Aug 31, 2025 | $15.11K | -42.8% |
| Q3 FY2025CQ2 2025 | May 31, 2025 | $13.65K | -81.4% |
| Q2 FY2025CQ1 2025 | Feb 28, 2025 | $45.68K | +23.0% |
| Q1 FY2025CQ4 2024 | Nov 30, 2024 | $17.34K | -78.8% |
| Q4 FY2024CQ3 2024 | Aug 31, 2024 | $26.42K | -79.6% |
| Q3 FY2024CQ2 2024 | May 31, 2024 | $73.41K | +66.3% |
| Q2 FY2024CQ1 2024 | Feb 29, 2024 | $37.14K | -22.2% |
| Q1 FY2024CQ4 2023 | Nov 30, 2023 | $81.65K | +278.0% |
| Q4 FY2023CQ3 2023 | Aug 31, 2023 | $129.70K | +10.4% |
| Q3 FY2023CQ2 2023 | May 31, 2023 | $44.15K | -54.1% |
| Q2 FY2023CQ1 2023 | Feb 28, 2023 | $47.75K | -79.4% |
| Q1 FY2023CQ4 2022 | Nov 30, 2022 | $21.60K | -97.3% |
| Q4 FY2022CQ3 2022 | Aug 31, 2022 | $117.52K | -91.5% |
| Q3 FY2022CQ2 2022 | May 31, 2022 | $96.28K | -95.2% |
| Q2 FY2022CQ1 2022 | Feb 28, 2022 | $231.64K | -82.6% |
| Q1 FY2022CQ4 2021 | Nov 30, 2021 | $786.41K | +327.3% |
| Q4 FY2021CQ3 2021 | Aug 31, 2021 | $1.39M | +78.3% |
| Q3 FY2021CQ2 2021 | May 31, 2021 | $1.99M | +455.4% |
| Q2 FY2021CQ1 2021 | Feb 28, 2021 | $1.33M | +127.3% |
| Q1 FY2021CQ4 2020 | Nov 30, 2020 | $184.03K | -42.4% |
| Q4 FY2020CQ3 2020 | Aug 31, 2020 | $777.61K | -77.9% |
| Q3 FY2020CQ2 2020 | May 31, 2020 | $357.63K | -27.5% |
| Q2 FY2020CQ1 2020 | Feb 29, 2020 | $586.97K | -88.6% |
| Q1 FY2020CQ4 2019 | Nov 30, 2019 | $319.34K | -95.1% |
| Q4 FY2019CQ3 2019 | Aug 31, 2019 | $3.52M | +152.8% |
| Q3 FY2019CQ2 2019 | May 31, 2019 | $493.50K | -77.7% |
| Q2 FY2019CQ1 2019 | Feb 28, 2019 | $5.17M | +80.4% |
| Q1 FY2019CQ4 2018 | Nov 30, 2018 | $6.58M | +127.8% |
| Q4 FY2018CQ3 2018 | Aug 31, 2018 | $1.39M | 0.0% |
| Q3 FY2018CQ2 2018 | May 31, 2018 | $2.22M | -30.6% |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | $2.86M | +405.0% |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | $2.89M | +938.4% |
| Q4 FY2017CQ3 2017 | Aug 31, 2017 | $1.39M | +7186.1% |
| Q3 FY2017CQ2 2017 | May 31, 2017 | $3.19M | – |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | $567.22K | – |
| Q1 FY2017CQ4 2016 | Nov 30, 2016 | $278.15K | – |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | $19.13K | – |
See a number that looks wrong?